Open research questions in Blood Coagulation and Thrombosis Mechanisms
94 gap statements mined from Blood Coagulation and Thrombosis Mechanisms papers in our 4.5M-paper local library, which holds 424 papers on the topic — drawn mostly from each paper's own stated research gap, future-work, challenge and limitation notes, and its abstract. The ones listed below are a selection still marked open; each names the study that raised it, with a DOI link where the paper has one.
What the literature leaves open
However, the benefit of thrombectomy in children with LVO and mild presenting symptoms remains uncertain.
Variants of methylenetetrahydrofolate reductase ( MTHFR ) and of the plasminogen activator inhibitor-1 gene ( SERPINE1 /PAI-1) may increase this risk, but data from Central Asian populations are scarce.
MTHFR (rs1801133) and SERPINE1/PAI-1 (−675 4G/5G) gene polymorphisms and their association with spontaneous abortion and missed pregnancy in an ethnic Uzbek population: a case–control study · 2026 · DOIWhile existing structures have revealed inactive and active conformations, the ligand-dependent conformational energy landscape governing PAR1 activation remains poorly understood.
Energy Landscape Sampling Reveals Ligand-Dependent Structural Dynamics of the Protease-Activated Receptor 1 · 2026 · DOICONCLUSIONS: High-quality data on anticoagulant prophylaxis for pediatric VTE prevention are scarce.
ASH/ISTH 2026 guidelines for anticoagulant prophylaxis in pediatric patients at risk of venous thromboembolism · 2026 · DOIHigh-quality data on anticoagulant prophylaxis for pediatric VTE prevention are scarce.
ASH/ISTH 2026 guidelines for anticoagulant prophylaxis in pediatric patients at risk of venous thromboembolism · 2026 · DOIAge and sex have been shown to affect TG parameters, but no consensus has been reached on the subject.
Age- and sex-dependency of thrombin generation parameters in the general Italian population: the Moli-sani study · 2025 · DOIBACKGROUND: Thromboprophlyaxis for the prevention of venous thromboembolism during pregnancy and the puerperium is widespread, but there is a lack of evidence on the risks and benefits of thromboprophylaxis within this population.
What influences women’s decisions to participate in trials for prevention of venous thromboembolism during pregnancy and the puerperium: a qualitative study · 2025 · DOIThere are relatively few reports on fetal Bartter syndrome, but it has been documented that the condition can increase the incidence of prematurity and hypovolemia.
Fetal umbilical vein thrombosis associated with fetal bartter syndrome: an unusual case report and literature review · 2025 · DOIWhile many of the existing data stem from studies in arterial ischemic stroke, functional outcomes in hemorrhagic stroke, and particularly pediatric intracerebral hemorrhage, remain largely understudied.
Pediatric Intracerebral Hemorrhage Management—Consensus Statement of the International Pediatric Stroke Organization—Part 2: Outcomes, Rehabilitation, and Transition to Adulthood · 2025 · DOIFurther experimental, translational, and epidemiologic studies are warranted to delineate underlying mechanisms and to evaluate thromboembolic safety in pharmacologic IL-6 signaling inhibition.
Genetic Downregulation of Interleukin‐6 Signaling, Coagulation Function, and Risk of Thromboembolic Disease · 2025 · DOIBACKGROUND: Although genetic evidence supports IL-6 (interleukin-6) signaling inhibition as protective against atherosclerotic disease, its potential effects on thromboembolic outcomes are not well established.
Genetic Downregulation of Interleukin‐6 Signaling, Coagulation Function, and Risk of Thromboembolic Disease · 2025 · DOIABSTRACT: Risk factors for recurrent venous thromboembolism (VTE) in children are poorly understood, and concerns remain about the risks of anticoagulant therapy in children.
Epidemiological data on venous thromboembolism (VTE) in children and adolescents is sparse and available primarily for the USA.
Burden and management of venous thromboembolism in children and adolescents (2004–2023): a Swiss nationwide epidemiological study · 2025 · DOIThe low number of epidemiological studies suggests that further research of this type is needed to fully understand the incidence and risk factors in young stroke.
An international perspective on young stroke incidence and risk factors: a scoping review · 2024 · DOIBackground: The mechanism by which combined oral contraceptives (COCs) lead to hypercoagulation is not fully understood, although activated protein C (APC) pathway resistance has been implicated.
Thrombomodulin is a stronger indicator of combined oral contraceptives-induced activated protein C pathway resistance in the thrombin generation test than activated protein C · 2024 · DOIHowever, it remains unclear which reagent is better suited for the detection of APC pathway resistance.
Thrombomodulin is a stronger indicator of combined oral contraceptives-induced activated protein C pathway resistance in the thrombin generation test than activated protein C · 2024 · DOICysteine proteases calpains contribute to heart failure (HF), but it remains unknown whether their inhibition provides any benefit compared to standard pharmacological treatment for HF.
Efficacy of a cysteine protease inhibitor compared with enalapril in murine heart failure models · 2024 · DOIHowever, data regarding the association with early stent thrombosis (ST) is sparse.
The interaction between complement and coagulation activation might be relevant for clinical outcomes in STEMI patients and warrants further investigation.
Combined activation of complement and coagulation is associated with myocardial injury in ST-elevation myocardial infarction · 2024 · DOIWe hypothesize that CFD can be an important modulator of the inflammation-remodeling cascade post MI, but the specific mechanism remains elusive.
Complement factor D deficiency ameliorates adverse cardiac remodelling by inhibiting C5a-C5aR mediated ISGs+ neutrophil activation post myocardial infarction · 2024 · DOIHowever, the role of APC and APC-biased PAR1 signaling in thrombin generation, inflammation, and endothelial activation in SCD remains unexplored.
Biased agonism of protease-activated receptor-1 regulates thromboinflammation in murine sickle cell disease · 2024 · DOIHowever, little is known regarding the release mechanism and properties of TM536.
Thrombomodulin (p.Cys537Stop) is released from cells by an unusual membrane insertion/leakage mechanism · 2024 · DOIIn vitro assays have established that therapeutic heparins promote the anticoagulant function of AT by binding D-helix and activating the serpin, however, the contribution of vascular GAGs to D-helix-dependent anticoagulant function of AT has remained poorly understood in vivo.
Although 7% of the population is homozygous for the G haplotype (F5-G/G), the underlying mechanism of VTE protection is poorly understood.
The common VTE-protective G haplotype of F5 increases factor V-short, TFPI function, and risk of bleeding · 2024 · DOIFurther studies are needed to validate the study's findings and to develop personalized anticoagulation strategies for postpartum VTE patients. Research is needed to examine the long-term outcomes of postpartum VTE patients treated with LMWH. Studies are needed to investigate the cost-effectiveness of personalized anticoagulation strategies for postpartum VTE patients.
Monitoring anti-Xa levels and thromboelastography in puerperal venous thromboembolism: a prospective cohort study · 2026 · DOI
Most-cited papers in Blood Coagulation and Thrombosis Mechanisms
- Mutation in blood coagulation factor V associated with resistance to activated protein C · Nature · 1994 · 2,901 citations
- Disseminated Intravascular Coagulation · New England Journal of Medicine · 1999 · 1,262 citations
- Association Between CYP2C9 Genetic Variants and Anticoagulation-Related Outcomes During Warfarin Therapy · JAMA · 2002 · 795 citations
- Thrombosis, abortion, cerebral disease, and the lupus anticoagulant. · BMJ · 1983 · 774 citations
- Neonatal Thrombosis: Report of a Prospective Canadian and International Registry · PEDIATRICS · 1995 · 454 citations
- The Value of Family History as a Risk Indicator for Venous Thrombosis · Archives of Internal Medicine · 2009 · 253 citations
- Risk of Recurrent Venous Thromboembolism in Patients With Common Thrombophilia · Archives of Internal Medicine · 2006 · 240 citations
- Bedside assessment of fibrinogen level in postpartum haemorrhage by thrombelastometry · BJOG An International Journal of Obstetrics & Gynaecology · 2009 · 196 citations
- Factor XIII: Structure, Activation, and Interactions with Fibrinogen and Fibrin · Annals of the New York Academy of Sciences · 2001 · 181 citations
- Biomarkers of endothelial activation and dysfunction in cardiovascular diseases · Reviews in Cardiovascular Medicine · 2022 · 176 citations
Most recent work
- ASH/ISTH 2026 guidelines for anticoagulant prophylaxis in pediatric patients at risk of venous thromboembolism · Blood Advances · 2026
- Sex Hormone Influences on Venous Thrombotic and Cardiovascular Risk · New England Journal of Medicine · 2026
- Tissue Factor as a Prognostic and Therapeutic Biomarker in Resected Pancreatic Cancer · Annals of Surgical Oncology · 2026
- Lipoprotein apheresis in the era of new lipid-lowering therapies · European Heart Journal · 2026
- Targeting PAR1 biased signaling with parmodulin reduces thromboinflammation and acute lung injury in sickle cell disease · Blood Advances · 2026
- Thrombin concentration shapes endothelial extracellular vesicle profiles with divergent inflammatory functions · Blood Advances · 2026
- A comprehensive multicenter study assessing the impact of abelacimab, asundexian, and milvexian on coagulation assays · Blood Advances · 2026
- Placental Versus Complement Biology in Postpartum Thrombotic Microangiopathy Attribution · American Journal of Kidney Diseases · 2026
- Incidence of Childhood Stroke and Association With Recent Infection · Neurology · 2026
- Thrombectomy for Pediatric Large Vessel Occlusion Stroke With Mild Presenting Symptoms · Neurology · 2026
Find a gap in your own Blood Coagulation and Thrombosis Mechanisms sub-topic
This page shows what the Blood Coagulation and Thrombosis Mechanisms literature already flags as unresolved. To narrow it to your specific question, search the Research Gap Finder: the search is free with a free account and lists the papers closest to your topic first. Unlocking that topic (50 credits, charged once) fills the comparison table from our 4.5M-paper local library and writes the gaps from its rows.
Open the Research Gap Finder →